PATENT DUCTUS ARTERIOSUS
Clinical trials for PATENT DUCTUS ARTERIOSUS explained in plain language.
Never miss a new study
Get alerted when new PATENT DUCTUS ARTERIOSUS trials appear
Sign up with your email to follow new studies for PATENT DUCTUS ARTERIOSUS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Premature baby heart trial: to treat or not to treat?
Disease control OngoingThis study looked at whether actively treating a heart condition called patent ductus arteriosus (PDA) in premature infants is better than watching and waiting. About 482 babies born very early (22-28 weeks) were included. The main goal was to see which approach reduces the risk …
Matched conditions: PATENT DUCTUS ARTERIOSUS
Phase: PHASE3 • Sponsor: NICHD Neonatal Research Network • Aim: Disease control
Last updated May 26, 2026 10:59 UTC
-
Heart hole closer under watch in tiny tots
Disease control OngoingThis study looks at how safe and effective a device called the Amplatzer Piccolo Occluder is for closing a common heart hole (PDA) in small babies. About 70 babies weighing at least 700 grams will be followed for 6 months after the procedure. The goal is to track any complication…
Matched conditions: PATENT DUCTUS ARTERIOSUS
Sponsor: Abbott Medical Devices • Aim: Disease control
Last updated May 19, 2026 11:46 UTC
-
Study aims to end needless treatments for preemie heart condition
Knowledge-focused OngoingThis study follows 526 preterm infants born before 30 weeks who have a condition called patent ductus arteriosus (PDA), where a fetal blood vessel stays open too long. Researchers want to find out which babies will close this vessel on their own and which ones are at risk for ser…
Matched conditions: PATENT DUCTUS ARTERIOSUS
Sponsor: Nationwide Children's Hospital • Aim: Knowledge-focused
Last updated May 18, 2026 12:04 UTC